Altered DNA methylation profile in idiopathic pulmonary fibrosis.
暂无分享,去创建一个
Xiangyu Zhang | Kui Zhang | Namasivayam Ambalavanan | James S Hagood | David K Crossman | N. Ambalavanan | Hui Liu | J. Hagood | V. Thannickal | Y. Sanders | B. Halloran | X. Zhang | D. Crossman | M. Bray | Kui Zhang | Victor J Thannickal | Brian Halloran | Hui Liu | Yan Y Sanders | Molly Bray | Xiangyu Zhang
[1] P. Barnes,et al. Increased production of the potent oxidant peroxynitrite in the lungs of patients with idiopathic pulmonary fibrosis. , 1997, American journal of respiratory and critical care medicine.
[2] J. Iovanna,et al. Tumor Protein p53-Induced Nuclear Protein (TP53INP1) Expression in Medullary Thyroid Carcinoma: A Molecular Guide to the Optimal Extent of Surgery? , 2010, World Journal of Surgery.
[3] M. Ebina,et al. Altered expression of tight junction molecules in alveolar septa in lung injury and fibrosis. , 2012, American journal of physiology. Lung cellular and molecular physiology.
[4] J. McPherson,et al. MethylScreen: DNA methylation density monitoring using quantitative PCR. , 2007, BioTechniques.
[5] B. Dahal,et al. The Role of Dimethylarginine Dimethylaminohydrolase in Idiopathic Pulmonary Fibrosis , 2011, Science Translational Medicine.
[6] E. White,et al. Hypermethylation of PTGER2 confers prostaglandin E2 resistance in fibrotic fibroblasts from humans and mice. , 2010, The American journal of pathology.
[7] Naftali Kaminski,et al. Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis. , 2006, American journal of respiratory and critical care medicine.
[8] A. Miyajima,et al. A novel nuclear zinc finger protein EZI enhances nuclear retention and transactivation of STAT3 , 2002, The EMBO journal.
[9] M. Skinner. Role of epigenetics in developmental biology and transgenerational inheritance. , 2011, Birth defects research. Part C, Embryo today : reviews.
[10] M. Esteller,et al. Profiling epigenetic alterations in disease. , 2011, Advances in experimental medicine and biology.
[11] Jin Woo Song,et al. Gene expression profiles of acute exacerbations of idiopathic pulmonary fibrosis. , 2009, American journal of respiratory and critical care medicine.
[12] Yi Qu,et al. Global profiling of histone and DNA methylation reveals epigenetic-based regulation of gene expression during epithelial to mesenchymal transition in prostate cells , 2010, BMC Genomics.
[13] C. B. Alexander,et al. Loss of fibroblast Thy-1 expression correlates with lung fibrogenesis. , 2005, The American journal of pathology.
[14] G. Laurent,et al. STAT3-mediated signaling dysregulates lung fibroblast-myofibroblast activation and differentiation in UIP/IPF. , 2012, The American journal of pathology.
[15] K. Nagai,et al. The Role of Catalase in Pulmonary Fibrosis , 2010, Respiratory research.
[16] M. Gleave,et al. TP53INP1 overexpression in prostate cancer correlates with poor prognostic factors and is predictive of biological cancer relapse , 2012, The Prostate.
[17] J. Whitsett,et al. Signaling pathways in the epithelial origins of pulmonary fibrosis , 2010, Cell cycle.
[18] J. Hagood,et al. Epigenetic regulation of thy-1 by histone deacetylase inhibitor in rat lung fibroblasts. , 2011, American journal of respiratory cell and molecular biology.
[19] J. Lasky,et al. Abrogation of TGF-beta1-induced fibroblast-myofibroblast differentiation by histone deacetylase inhibition. , 2009, American journal of physiology. Lung cellular and molecular physiology.
[20] M. Gleave,et al. TP53INP1 as new therapeutic target in castration‐resistant prostate cancer , 2012, The Prostate.
[21] Y. Soini,et al. Claudin-1, −2, −3, −4, −5, and −7 in Usual Interstitial Pneumonia and Sarcoidosis , 2009, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[22] Donghui Li,et al. Association of CHFR Promoter Methylation with Disease Recurrence in Locally Advanced Colon Cancer , 2011, Clinical Cancer Research.
[23] J. Hagood,et al. Enhanced myofibroblastic differentiation and survival in Thy-1(-) lung fibroblasts. , 2007, American journal of respiratory cell and molecular biology.
[24] S. Phan. Fibroblast phenotypes in pulmonary fibrosis. , 2003, American journal of respiratory cell and molecular biology.
[25] S. Bulun,et al. Hypermethylation of the CpG Island Spanning From Exon II to Intron III is Associated With Steroidogenic Factor 1 Expression in Stromal Cells of Endometriosis , 2011, Reproductive Sciences.
[26] A. Bird,et al. Number of CpG islands and genes in human and mouse. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[27] D. Lane,et al. Regulation of the p14ARF promoter by DNA methylation , 2008, Cell cycle.
[28] Xi Chen,et al. BVES regulates EMT in human corneal and colon cancer cells and is silenced via promoter methylation in human colorectal carcinoma. , 2011, The Journal of clinical investigation.
[29] N. Kaminski,et al. Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis , 2006, The Journal of experimental medicine.
[30] Venkateshwar G. Keshamouni,et al. PPAR-γ agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis , 2008 .
[31] Kohta Ikegami,et al. Interplay between DNA methylation, histone modification and chromatin remodeling in stem cells and during development. , 2009, The International journal of developmental biology.
[32] A. Carrier,et al. Tumor protein 53-induced nuclear protein 1 is a major mediator of p53 antioxidant function. , 2009, Cancer research.
[33] T. Bestor,et al. Eukaryotic cytosine methyltransferases. , 2005, Annual review of biochemistry.
[34] J. Roman,et al. The Role of PPARs in Lung Fibrosis , 2007, PPAR research.
[35] S. Zöchbauer-Müller,et al. Lung cancer: From single-gene methylation to methylome profiling , 2010, Cancer and Metastasis Reviews.
[36] M. Morosini,et al. Analysis of bronchoalveolar lavage fluid proteome from systemic sclerosis patients with or without functional, clinical and radiological signs of lung fibrosis , 2006, Arthritis research & therapy.
[37] G. Nuovo,et al. Thy-1 promoter hypermethylation: a novel epigenetic pathogenic mechanism in pulmonary fibrosis. , 2008, American journal of respiratory cell and molecular biology.
[38] Naftali Kaminski,et al. MMP1 and MMP7 as Potential Peripheral Blood Biomarkers in Idiopathic Pulmonary Fibrosis , 2008, PLoS medicine.
[39] Christian B. Woods,et al. Quantitative analysis of associations between DNA hypermethylation, hypomethylation, and DNMT RNA levels in ovarian tumors , 2006, Oncogene.
[40] François Fuks,et al. DNA methylation and histone modifications: teaming up to silence genes. , 2005, Current opinion in genetics & development.
[41] M. Selman,et al. Idiopathic pulmonary fibrosis: new insights in its pathogenesis. , 2002, The international journal of biochemistry & cell biology.
[42] T. Martin,et al. Zinc Finger Protein 467 Is a Novel Regulator of Osteoblast and Adipocyte Commitment* , 2010, The Journal of Biological Chemistry.
[43] A. Camargo,et al. Epigenetic Changes of CXCR4 and Its Ligand CXCL12 as Prognostic Factors for Sporadic Breast Cancer , 2011, PloS one.
[44] F. Martinez,et al. Negative regulation of myofibroblast differentiation by PTEN (Phosphatase and Tensin Homolog Deleted on chromosome 10). , 2006, American journal of respiratory and critical care medicine.
[45] J. Herman,et al. Gene silencing in cancer in association with promoter hypermethylation. , 2003, The New England journal of medicine.
[46] Peter A. Jones,et al. The Epigenomics of Cancer , 2007, Cell.
[47] V. Poletti,et al. Migratory marker expression in fibroblast foci of idiopathic pulmonary fibrosis , 2006, Respiratory research.
[48] E. Liu,et al. THY1 is a candidate tumour suppressor gene with decreased expression in metastatic nasopharyngeal carcinoma , 2005, Oncogene.
[49] D. Morton,et al. AIM1 and LINE-1 Epigenetic Aberrations In Tumor and Serum Relate to Melanoma Progression and Disease Outcome , 2012, The Journal of investigative dermatology.
[50] G. Rosen,et al. SPARC Suppresses Apoptosis of Idiopathic Pulmonary Fibrosis Fibroblasts through Constitutive Activation of β-Catenin* , 2010, The Journal of Biological Chemistry.
[51] J. Norris,et al. Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003. , 2007, American journal of respiratory and critical care medicine.